Related references
Note: Only part of the references are listed.Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler et al.
NATURE (2021)
Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2
Xingguang Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases
Marie Von Lilienfeld-Toal et al.
LEUKEMIA (2020)
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY (2020)
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands
Jaap van Doesum et al.
LEUKEMIA (2020)
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract
Fengyu Hu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
Lindsey E. Roeker et al.
LEUKEMIA (2020)
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
El-ad David Amir et al.
NATURE BIOTECHNOLOGY (2013)
Moderate mutation rate in the SARS coronavirus genome and its implications
ZM Zhao et al.
BMC EVOLUTIONARY BIOLOGY (2004)
Share Paper
